期刊文献+

YB-1高表达与宫颈癌患者预后的关系 被引量:3

Association between higher expression of Y-box-binding protein-1 and poor prognosis in cervical cancer
下载PDF
导出
摘要 目的研究YB-1在宫颈癌中的高表达与宫颈癌病人预后的关系。方法用免疫组化方法,分析2002年1月~2009年1月经病理证实的46例宫颈癌标本组织中YB-1的表达,探讨YB-1与宫颈癌的关系,并用SPSS软件对结果进行分析。结果 YB-1高表达的宫颈癌患者复发率更高,并且有更短的无病进展期(P=0.035)和总的生存时间(P=0.013),多因素回归分析显示YB-1高表达是宫颈癌的独立预后因素。结论本项研究中,YB-1高表达患者预后差,YB-1高表达可能是宫颈癌独立预后因素。 Objective This study aimed at researching the effect of Y-box-binding protein-1(YB-1) in cervical cancer tissue,and the relationship between YB-1 and cervical cancer.Methods We selected 46 cervical cancer's tissues to detect YB-1 expression with immunity histochemical method.All of them were verified by pathology.Results Higher expression of YB-1 was associated with an increased potential for relapse,poor disease-free survival,and reduced overall survival.Higher expression of YB-1 could be an independent risk factor for poor prognosis in patients with cervical cancer.Conclusion Our data show that cervical cancer patients with higher expression of YB-1 have poor prognosis and YB-1 may be independent prognostic factors of cervical cancer.
出处 《西部医学》 2012年第10期1876-1878,1884,共4页 Medical Journal of West China
基金 四川省卫生厅基金课题(No:110543)
关键词 YB-1 宫颈癌 预后 Y-box-binding protein-1 Cervical cancer Prognosis
  • 相关文献

参考文献24

  • 1Jemal A, Bray F, Center MM, et al. Global cancer tatistics [J]. CACancerJClin, 2011,61:69-90.
  • 2Petignat P, Roy M. Diagnosis and management of cervical canc- er[J]. BMJ, 2007,8:335-765.
  • 3Poujade O, Moriee P, Rouzier R, et al. Pathologieresponse rate after concomitant neo-adjuvant radiotherapy andchemotherapy for adenocarcinoma of the uterine eervix a retrospectivemulti- centrie study [J]. Int J Gynecol Cancer, 2010,20:815.
  • 4Cheng HY, Zhang YN, Wu QL, etal. Expression of beclin 1, an autophagy-related protein, in human cervical carcinoma and its clinical significance [J]. Eur J Gynaecol Oncol, 2012,33(1) 15-20.
  • 5Peng X, Wu Z, Yu L, et al. Overexpression of cystic fibrosis transmembrane conductance regulator (CFTR) is associated with human cervical cancer malignancy, progression and progno- sis [J]. Gynecol Oncol, 2012,125(2) :470.
  • 6Zhang T, Zhao C, Chen D, et al. Overexpression of AQP5 in cervical cancer: correlation with clinicopathological features and prognosis [J]. Med Oneol, 2011,3.
  • 7Lasham A, Moloney S, Hale T, et al. The Y-box-binding pro- tein, YB1, is a potential negative regulator of the p53 tumor suppressor[J]. J Biol Chem, 2003, 278(37): 35516-35523.
  • 8Mertens P R, Steinmarm K, Alonso-Jaume M A, et al. Combi- natorial interactions of p53, activating protein-2, and YB-1 with a single enhancer element regulate gelatinase A expression in ne- oplastic cells [J]. J Biol Chem, 2002, 277 (28): 24875-24882.
  • 9Shibahara K, Uchiumi T,Fukuda T, et al. Targeted diaruption of one allele of the Y-box binding protein-1 (Yb-1)gene in, embry- onic stemcls and increased sensitivity to cisplatin and mitomyein C[J]. Cancer Sri,2004,95(4) :348-353.
  • 10HANZAWA K, MOMOSE S,et al. Y-box binding protein-1 ex- pression in diffuse large B-cell lymphoma: an impact on progno- sis in the rituximab era [J]. Leukemia - Lymphoma, Novem- ber, 2010, 51(11): 2054-2062.

同被引文献25

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部